Publications
Short-term KRP203 and posttransplant cyclophosphamide for graft-versus-host disease prophylaxis
Bone Marrow Transplantation (2020) Yokoyama, Teshima et al
ASBMT 2018: The Role of S1PR1 Agonism in Thymus-Dependent T-Cell Regeneration and Graft-vs.-Tumor Activity Following Experimental Allogeneic Hematopoietic Stem Cell Transplantation
Vollmer, Krenger (2018)
Insights into the mechanism of FTY720 and compatibility with regulatory T cells for the inhibition of graft-versus-host disease (GVHD)
Patricia A. Taylor et al
Sphingosine 1-Phosphate Signaling and Its Pharmacological Modulation in Allogeneic
Hematopoietic Stem Cell Transplantation, Smith & Gergely 2017
ASBMT 2018: The Role of S1PR1 Agonism in Thymus-Dependent Generation of Autoreactive T Cells during Experimental Acute Graft-vs.-Host Disease
Vollmer and Krenger
Targeting Cytokine Signaling and Lymphocyte Traffic via Small Molecules in Inflammatory Bowel Disease: JAK Inhibitors and S1PR Agonists
Frontz Pharmacol – Perez et al (2019)
GVHD prophylaxis with KRP203, a SPHINGOSINE-1-PHOSPHATE RECEPTOR MODULATOR, is safe and may have a potential to improve
Poster, Heim et al
S1P signaling: new therapies and opportunities F1000 Prime reports
Gonzales 2014
Contact Us
Priothera Ltd
88 Harcourt Street, Dublin 2, D02 DK18, Ireland
Priothera Ltd
88 Harcourt Street, Dublin 2,
D02 DK18, Ireland
Priothera SAS France
9 Rue du Temple, Saint Louis, 68300, France
